title: [Iron deficiency without anemia: where are we in 2012?].
abstract: Should we treat iron deficiency without anemia? The simple fact that the question can be formulated already leads to controversies. During the past years, the development of a new formulation of intravenous iron has helped fuel the controversy. What is the situation in 2012? This article gives a practical point of view on the actual situation and provides indications on the use of new intravenous medications.
authors.affiliation: Département de médecine et santé communautaires, PMU, Lausanne. bernard.favrat@chuv.ch
authors.forename: B
authors.initials: B
authors.lastname: Favrat
authors.forename: S
authors.initials: S
authors.lastname: Waldvogel Abramowski
authors.forename: P
authors.initials: P
authors.lastname: Vaucher
authors.forename: J
authors.initials: J
authors.lastname: Cornuz
authors.forename: J-D
authors.initials: JD
authors.lastname: Tissot
mesh_terms: D018798:Anemia, Iron-Deficiency / Q000188:drug therapy; D015195:Drug Design; D006801:Humans; D007262:Infusions, Intravenous; D007501:Iron / Q000008:administration & dosage; D058085:Iron Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D000090463:Iron Deficiencies
chemical_list: D058085:Iron Compounds; D007501:Iron